Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Minimal Sulfated Carbohydrates for Recognition by L-selectin and the MECA-79 Antibody
2000 StandoutNobel
Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?
1999
Aspirin as an Antiplatelet Drug
1994
Cellular basis of ventricular remodeling after myocardial infarction
1991
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Unstable angina: Pathogenesis, diagnosis, and treatment
1993
Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure
1994
Prospects for Cardiovascular Research
2001 StandoutNobel
Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure
2003
Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: A randomized, double-blind, placebo-controlled study
1998
Exercise Standards for Testing and Training
2013 Standout
The Prognostic Value of Serum Troponin T in Unstable Angina
1992
Antiplatelet Effects of MK‐852, a Platelet Fibrinogen Receptor Antagonist, in Healthy Volunteers
2000
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Coronary heart disease: seven dietary factors
1991 Standout
Methods of estimation of mitral valve regurgitation for the cardiac surgeon
2009
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy
1989
Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty
1993
Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy
1998
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes
2003
Platelet Activation and Atherothrombosis
2007 Standout
Regulation of Coronary Blood Flow During Exercise
2008
Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?
2004
The Role of Echocardiography in the Diagnosis and Management of Heart Failure
2003
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location
1988
Parenteral inotropic support for advancedcongestive heart failure
1998
Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions
2003
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Platelets in inflammation and atherogenesis
2005 Standout
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Functional, angiographic and intracoronary doppler flow characteristics in symptomatic patients with myocardial bridging: Effect of short-term intravenous beta-blocker medication
1996
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
1996 Standout
Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study
1996
Hypertrophic Cardiomyopathy
2002 Standout
The effects of a myocardial bridge on coronary atherosclerosis and ischaemia
1998
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
1999
Exercise-induced T-wave normalization predicts recovery of regional contractile function after anterior myocardial infarction
1998
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome
1998
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Arterial thrombosis—insidious, unpredictable and deadly
2011
Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging
1994
Hypertrophic Cardiomyopathy and Sudden Death
1988
Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes
2005
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Procedural and In-Hospital Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions of Coronary Arteries 2002 to 2008
2009
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Antiplatelet therapy: in search of the 'magic bullet'
2003
Anti-adhesive therapeutics: A new class of anti-inflammatory agents
1994
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Impact of wall constraint on velocity distribution in proximal flow convergence zone Implications for color Doppler quantification of mitral regurgitation
1996
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
1985
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Value of Electron-Beam Computed Tomography for the Noninvasive Detection of High-Grade Coronary-Artery Stenoses and Occlusions
1998
Atherosclerosis: Basic Mechanisms
1995 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms
1990
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Depression and Coronary Heart Disease
2008 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
1994
β-Blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol
2000
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
1999 Standout
Platelets and Cardiovascular Disease
2002
The stunned myocardium: prolonged, postischemic ventricular dysfunction.
1982 Standout
Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy.
1987
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.
1996
Time course of functional and biochemical recovery of myocardium salvaged by reperfusion
1983
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy.
1993
Direct detection of activated platelets and platelet-derived microparticles in humans
1990
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
1996 Standout
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
1989
Coronary Plaque Disruption
1995 Standout
Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.
1991
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1997 Standout
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
1995 Standout
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
1985
Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
1984
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Hypertrophic Cardiomyopathy
1987
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Increased thromboxane biosynthesis in patients with acute cerebral ischemia.
1993
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States
2005 Standout
Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy.
1989
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy
1986
Works of W. Küpper being referenced
2008优秀广告“新”赏
1980
Noninvasive estimation of regurgitant flow rate and volume in patients with mitral regurgitation by doppler color mapping of accelerating flow field
1993
Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure
1992
Intrakoronare Thromben bei Patienten mit instabiler Angina pectoris
2008
Quantitation of coronary venous adenosine in patients: limitations evaluated by radioimmunoassay
1988
Intermittent infusion of dobutamine in the therapy of severe congestive heart failure-long-term effects and lack of tolerance
1992
Biochemical evidence of platelet activation in patients with persistent unstable angina
1987
Age, cardiovascular risk factors and coronary heart disease as determinants of platelet function in men. A multivariate approach
1991
Recanalization of chronic, totally occluded coronary arteries by new angioplasty systems
1990
Interrupting the adaptive changes in congestive heart failure
1991
Usefulness of transesophageal echocardiography in identifying small left ventricular apical thrombus
1993
Myocardial Thallium201imaging in hypertrophic obstructive cardiomyopathy
1981
Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease
1982
Haemodynamic and cardiac metabolic effects of the new β1 agonist prenalterol in patients with cardiac failure†
1983
Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure
1982
Intravenous Coronary Angiography with Dichromography using Synchrotron Radiation
1998
Left ventricular hemodynamics and function in acute myocardial infarction: Studies during the acute phase, convalescence and late recovery
1977
[Correlation between myocardial Thallium-201 kinetics, myocardial lactate metabolism and coronary angiographic findings in hypertrophic cardiomyopathy (author's transl)].
1980